
Clinical Pharmacology Essentials 2023
In August of 2023 ULS Presented the second year of training to the VA Health Care System to 80 Nurse Practioners. There was an overwhelming demand to attend the training. Consequently this course was created to allow all NPs who were unable to attend the course to benefit from its content. The course provides 16 hours of on demand pharmacotherapeutics. Each topic contains a recording, course slides, and a self-evaluation quiz. The recordings are designed to be watched on your smartphone or computer.
SALE! $99 for 16 Hours of CME Credit
Watch Topic 1 for FREE
Topic 1 : Pharmacokinetics, Pharmacodynamics basics of Drug/Drug and Drug/ Disease Interactions
Identify common drug interaction mechanisms including cytochrome P450 enzymes.
Identify relevant clinical drug interactions for common medications.
Delineate assessment and management strategies for each drug interaction.
-
Identify common drug interaction mechanisms including cytochrome P450 enzymes.
Identify relevant clinical drug interactions for common medications.
Delineate assessment and management strategies for each drug interaction.
-
Recognize factors leading to polypharmacy in the elderly.
2. Define inappropriate medications for elderly patients.
3. Describe tools to screen patients for polypharmacy.
4. Delineate best practices in polypharmacy through patient cases.
-
1. Topic 3: Infectious Disease
2. Topic 3A.: Review and discuss appropriate penicillin allergy assessment and intervention strategies for management.
3. Topic 3B: Discuss and determine overall role of newer antimicrobials.
4. Topic 3C: 1. Review standard and new drugs for prevention of HIV infection (HIV Prep) in High Risk Individuals.
-
1. Describe appropriate patient populations for weight loss pharmacotherapy.
2. Delineate key characteristics of various pharmacotherapy options including GLP-1 agonists.
-
1. Review medications and lifestyle modifications that are recommended for the treatment of cardiovascular disease
2. Apply recommendations from the American College of Cardiology/American Heart Association for treatment of patients with hypertension, hypercholesterolemia, heart failure with reduced ejection fraction and atrial fibrillation
3. Examine results from newer cardiovascular outcome trials evaluating the use of medications hypercholesterolemia and heart failure with reduced ejection fraction
4. Define the evidence and role in therapy of non-statin medications in the treatment of hypercholesterolemia
5. Create treatment plans that reduce the risk of cardiovascular disease
-
1. Compare and contrast the appropriate use, risks and benefits associated with colchicine, uric acid lowering drugs, steroids and NSAIDs in the management and prevention of gout
2. Explain the roles in therapy and safety concerns for non-biologic disease modifying antirheumatic agents (DMARDs), biologic DMARDs, corticosteroids, and NSAIDs in the treatment of RA
-
Review the functions of vitamins and minerals in the body.
2. Match the diseases caused with their vitamin deficiencies.
3. List foods high in certain vitamins and minerals.
4. Examine problems for vitamin and mineral deficiencies.
-
. Review the functions of vitamins and minerals in the body.
2. Match the diseases caused with their vitamin deficiencies.
3. List foods high in certain vitamins and minerals.
4. Examine problems for vitamin and mineral deficiencies.
-
1. Discuss traditional agents used to manage depression, anxiety and PTSD
2. Identify the role of newer agents (e.g., ketamine, psilocybin) in the treatment of depression, anxiety, and PTSD
3. Recognize cardiovascular adverse effects of psychiatric medications
4. Discuss the impact of genetics on drug response and its role in the pharmacologic management of patients
5. Explain specific important pharmacokinetic variations with pharmacologic agents in the treatment of mood disorders
-
1. Manage cardiac and thromboembolic related emergencies: hypertensive emergency, acute coronary syndrome, acute stroke, and rapid response scenarios
2. Outline the key tenets of diabetic ketoacidosis (DKA) management
3. Discuss best practices for improving outcomes in acute respiratory failure and sepsis
-
1. Describe pharmacologic properties and considerations of various forms of contraception
2. Identify key recommendations and updates for contraception, emergency contraception, and options for medication abortions
3. Evaluate the use of various forms of contraception in specific patient cases and scenarios
4. Recognize updates in pregnancy and lactation categories for medications
5. Discuss specific patient considerations related to updated pregnancy and lactation considerations
Expert Clinical Faculty
-
Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS
Clinical Professor, Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Clinical Pharma- cy Specialist, St. Joseph’s/ Candler Health System, Sa- vannah, Georgia. Co-founder of SERGE-45, practice-based research network, co-founder of TeachMePharm, drug therapy teaching platform.
-
Dr. Joshua Caballero
Associate Professor (Limited Term) for Clinical and Administrative Pharmacy at the College of Pharmacy. He received his undergraduate degree in Psychology from the University of Florida and his PharmD from the University of Tennessee Health Science Center in Memphis. During his postdoctoral training, he completed a PGY2 in Psychiatry at the University of Texas Health Science Center in San Antonio and a Pharmacotherapy Fellowship at The Ohio State University
-
Dr. Chelsea A. Keedy, PharmD, BCACP, CDTM
Dr. Keedy is a Clinical Pharmacy Specialist in Ambulatory Care at SJ/C Medical Group – Eisenhower. She is a Board Certified Ambulatory Care Pharmacist (BCACP) and holds a collaborative drug therapy management (CDTM) agreement. She is a member of ASHP, GSHP, and AACP and was selected as the GSHP Outstanding New Practitioner of the Year in 2020. She previously helped establish the health system’s Hepatitis C treatment clinic.
-
Dr. Lynn Lafferty, Pharm.D., ND, MBA, DACBN, MH
Endowed Assistant Clinical Professor
Dept: Barry and Judy Silverman College of Pharmacy Nova Southeastern University, Diplomate American Clinical Board of Nutrition, Master Herbalist . -
Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS, BCACP
Joseph Saseen is Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy and a Professor of Family Medicine. He also served as Vice Chair of the Department of Clinical Pharmacy for 10 years. Dr. Saseen has responsibilities for enhancing the school’s clinical enterprise, further developing sustainable clinical service models, and advocating for advancing the practice of pharmacy in the State of Colorado. His scholarly work includes almost 200 peer-reviewed publications and book chapters.
-
Dr. Andrea Sikora
Pharm.D., MSCR, FCCM, BCCCP Clinical Associate Professor University of Georgia, College of Pharmacy Clinical And Administrative Pharmacy, Augusta GADescription goes here
-
Dr. C. Wayne Weart | Pharm.D., BCPS, FASHP
Professor Emeritus of Family Medicine, Department of Family Medicine, Medical University of South Carolina, Professor Emeritus of Clinical Pharmacy & Outcome Sciences, South Carolina College of Pharmacy, MUSC Campus, Charleston, SC.